Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 3Gynecologic 2Head & Neck 1Genitourinary 1Breast 1

Conditions

Breast Neoplasms 1214Triple Negative Breast Neoplasms 281Ovarian Neoplasms 261Carcinoma, Non-Small-Cell Lung 247Colorectal Neoplasms 188Pancreatic Neoplasms 168Stomach Neoplasms 163Neoplasm Metastasis 156Neoplasms 155Lung Neoplasms 144Prostatic Neoplasms 143Melanoma 132Carcinoma, Renal Cell 102Squamous Cell Carcinoma of Head and Neck 101Endometrial Neoplasms 98Head and Neck Neoplasms 88Colonic Neoplasms 82Urinary Bladder Neoplasms 79Uterine Cervical Neoplasms 76Esophageal Neoplasms 75Sarcoma 71Breast Neoplasms, Male 68Small Cell Lung Carcinoma 65Carcinoma, Hepatocellular 59Carcinoma, Ovarian Epithelial 58Kidney Neoplasms 47Carcinoma, Transitional Cell 40Rectal Neoplasms 35Fallopian Tube Neoplasms 34Liver Neoplasms 32

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Cachexia × Breast × Clear all
NCT04803305 2024-01-12

Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia

Pfizer

Phase 1 Completed
18 enrolled 14 charts
BreastGastrointestinalGenitourinaryGynecologicThoracic

Anorexia, Breast Neoplasms, Cachexia, Carcinoma, Non-Small-Cell Lung, Fatigue, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡